Clinical trial
Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III…
NCT00002519 · Vanderbilt-Ingram Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002519 |
|---|---|
| Title | Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer |
| Official title | PH I Continuous Infusion Taxol in Combination With Thoracic Radiation Therapy in Untreated Locally Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Vanderbilt-Ingram Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | chemotherapy, paclitaxel, radiation therapy |
| Enrollment | 6 |
| Start date | Jan 1, 1997 |
| Primary completion | Jan 1, 2000 |
| Completion | Jan 1, 2000 |
| First posted | Apr 22, 2004 |
| Last update posted | May 3, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: